Breast Cancer Trial, Not Yet Recruiting NCT07698314 Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Not Yet Recruiting

NCT07698314
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 20 and 89 years old
  • Women who have been prescribed exercise as a standard part of their care
  • Women who have a confirmed diagnosis of a type of breast cancer (ductal carcinoma in situ or invasive breast cancer), proven by biopsy
  • Women who have already received at least one treatment for breast cancer, such as surgery, radiation therapy, chemotherapy, immunotherapy, or hormonal therapy — though women currently undergoing chemotherapy are not eligible; immunotherapy or targeted therapy is allowed
  • Women who have at least 3 months of experience doing supervised resistance (strength) training at the Allegheny Health Network Exercise Oncology Center

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • Women currently receiving chemotherapy (cytotoxic type) for breast cancer
  • People whom the study doctor determines cannot safely take part in group resistance training sessions
  • People with a severe condition affecting their joints, heart, or muscles that the study doctor considers unsafe for resistance training
  • Women who are pregnant
  • Males

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Colin Champ, MD, AHN Radiation Oncology

Phone: 412-330-6151

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Myokine Production After First Exercise Session; Change in Myokine Production After Final Exercise Session of Each Week; Change in Myokine Production After Final Exercise Session of the Month (End of Study)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov